The Innovative Therapies for Children with Cancer Consortium (ITCC) was founded in 2003. It is a non-profit organization.
ITCC brings together 54 European pediatric oncology departments with expertise in conducting early-stage studies in children and adolescents, as well as 22 European research laboratories. The goal of this organization is to develop novel therapies for the treatment of cancer in children and adolescents in collaboration with regulatory agencies, pharmaceutical companies, parents and patients.
In January 2011, ITCC was established as a European Category 1 network for pediatric research at the European Medicines Agency (EnprEMA).
The consortium consists of several committees, each of which addresses the unique problems of developing novel therapeutic strategies in pediatric oncology.
For more information, please visit the ITCC website.
